Residual renal function and mortality risk in hemodialysis patients

被引:284
作者
Shemin, D
Bostom, AG
Laliberty, P
Dworkin, LD
机构
[1] Rhode Isl Hosp, Div Renal, Providence, RI 02903 USA
[2] Brown Univ, Sch Med, Providence, RI 02912 USA
[3] Rhode Isl Renal Inst, Warwick, RI USA
关键词
residual renal function; mortality; hemodialysis (HD);
D O I
10.1053/ajkd.2001.25198
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Residual renal function, defined as the urinary clearance of urea and creatinine, is minimal in many patients treated with hemodialysis (HD) and tends to be ignored in most outcome studies involving HD patients. Recent studies showed that residual renal function, even at a low level, is influential in preventing mortality in the minority of patients with end-stage renal disease treated with peritoneal dialysis, This issue generally has not been examined in patients treated with HD, This prospective observational study of all 114 patients at a single community-based freestanding HD center is designed to examine the impact of residual renal function (defined as renal urea clearance and renal creatinine clearance derived from 24-hour urinary volumes) on modality over a 2-year period. During that period, 50 deaths occurred in 114 patients, The presence of residual renal function was protective against mortality (odds ratio for death, 0.44; 95% confidence interval, 0.24 to 0.81; P = 0,008), even after adjustment for duration of dialysis treatment, age, smoking, presence of diabetes, presence of cardiovascular disease, serum albumin level, and urea reduction rate. In conclusion, the presence of residual renal function, even at a low level, is associated with a lower mortality risk in HD patients. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 15 条
[1]   RESIDUAL RENAL-FUNCTION AND EFFECTIVE REHABILITATION IN CHRONIC DIALYSIS [J].
BONOMINI, V ;
ALBERTAZZI, A ;
VANGELISTA, A ;
BORTOLOTTI, GC ;
STEFONI, S ;
SCOLARI, MP .
NEPHRON, 1976, 16 (02) :89-99
[2]  
Churchill DN, 1996, J AM SOC NEPHROL, V7, P198
[3]   Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis [J].
Hartmann, J ;
Fricke, H ;
Schiffl, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (03) :366-373
[4]   EFFECT OF THE HEMODIALYSIS PRESCRIPTION ON PATIENT MORBIDITY - REPORT FROM THE NATIONAL COOPERATIVE DIALYSIS STUDY [J].
LOWRIE, EG ;
LAIRD, NM ;
PARKER, TF ;
SARGENT, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (20) :1176-1181
[5]   Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers [J].
McCarthy, JT ;
Jenson, BM ;
Squillace, DP ;
Williams, AW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (04) :576-583
[6]   Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis [J].
Merkus, MP ;
Jager, KJ ;
Dekker, FW ;
de Haan, RJ ;
Boeschoten, EW ;
Krediet, RT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) :69-79
[7]   MEASUREMENT OF RESIDUAL GLOMERULAR-FILTRATION RATE IN PATIENT RECEIVING REPETITIVE HEMODIALYSIS [J].
MILUTINOVIC, J ;
CUTLER, RE ;
HOOVER, P ;
MEIJSEN, B ;
SCRIBNER, BH .
KIDNEY INTERNATIONAL, 1975, 8 (03) :185-190
[8]  
Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556
[9]  
*NIH NAT I DIAB DI, 1997, US REN DAT SYST USRD
[10]   THE UREA REDUCTION RATIO AND SERUM-ALBUMIN CONCENTRATION AS PREDICTORS OF MORTALITY IN PATIENTS UNDERGOING HEMODIALYSIS [J].
OWEN, WF ;
LEW, NL ;
LIU, Y ;
LOWRIE, EG ;
LAZARUS, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :1001-1006